Barclays PLC Purchases 78,583 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Barclays PLC lifted its holdings in Avanos Medical, Inc. (NYSE:AVNSFree Report) by 446.2% during the third quarter, HoldingsChannel reports. The firm owned 96,194 shares of the company’s stock after purchasing an additional 78,583 shares during the period. Barclays PLC’s holdings in Avanos Medical were worth $2,311,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in the business. Quarry LP bought a new stake in shares of Avanos Medical in the third quarter valued at approximately $42,000. KBC Group NV raised its stake in Avanos Medical by 63.0% during the 3rd quarter. KBC Group NV now owns 2,833 shares of the company’s stock valued at $68,000 after purchasing an additional 1,095 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in Avanos Medical in the 2nd quarter valued at $70,000. XTX Topco Ltd acquired a new stake in Avanos Medical in the 2nd quarter worth $202,000. Finally, Intech Investment Management LLC bought a new position in shares of Avanos Medical during the 3rd quarter worth about $207,000. Institutional investors own 95.17% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd.

Check Out Our Latest Stock Analysis on AVNS

Avanos Medical Trading Down 0.1 %

Shares of AVNS opened at $16.02 on Thursday. The stock has a market cap of $736.23 million, a PE ratio of 47.12 and a beta of 0.95. The stock has a 50 day simple moving average of $19.43 and a 200-day simple moving average of $21.26. Avanos Medical, Inc. has a 1 year low of $15.86 and a 1 year high of $25.36. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

About Avanos Medical

(Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Featured Articles

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNSFree Report).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.